adalimumab
English edit
Etymology edit
From ada- (of unknown origin) + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).
Pronunciation edit
- (General American) IPA(key): /ˌeɪ.dəˈlɪm.jəˌmæb/
Noun edit
adalimumab (uncountable)
- (pharmacology) An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.
Translations edit
monoclonal antibody
|
References edit
- “adalimumab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.